{"transactions":[{"id":2098174,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2022-12-02T06:01:11.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":30000,"price":0.7635,"value":22905.0,"ownership":{"direct":true},"balance_after":174465,"source":{"system":"sec-edgar","filing":"0001683168-22-008144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000168316822008144/ownership.xml","form_type":"4"}},{"id":2242283,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2022-06-06T12:36:08.000Z","date":"2022-06-03","kind":"purchase","acquired":true,"shares":25000,"price":1.22,"value":30500.0,"ownership":{"direct":true},"balance_after":144465,"source":{"system":"sec-edgar","filing":"0001683168-22-004178","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000168316822004178/ownership.xml","form_type":"4"}},{"id":2858977,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2021-02-16T12:23:20.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":20000000,"price":0.001,"value":20000.0,"ownership":{"direct":true},"balance_after":23893086,"source":{"system":"sec-edgar","filing":"0001128732-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873221000001/primary_doc.xml","form_type":"4"}},{"id":3082618,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2020-07-15T12:09:52.000Z","date":"2019-12-31","kind":"grant","acquired":false,"shares":323673,"price":0.001,"value":323.673,"ownership":{"direct":false,"nature":"Held by TRT Pharma Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Effective December 31, 2019, 4019318 Canada, Inc., an entity controlled by the Reporting Person, effectuated a consolidation with Advanomics Corporation, an entity controlled by the Chief Executive Officer of the Issuer.  The resulting consolidated entity changed its name to TRT Pharma Inc.  The consolidation resulted in the transfer of 323,673 shares of post-reverse splits of the Issuer's Common Stock to TRT Pharma Inc. and the Reporting Person no longer being a control person of TRT Pharma Inc."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001128732-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873220000005/primary_doc.xml","form_type":"4"}},{"id":3082617,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2020-07-15T12:09:52.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":1300000,"price":0.001,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."}],"balance_after":3893086,"source":{"system":"sec-edgar","filing":"0001128732-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873220000005/primary_doc.xml","form_type":"4"}},{"id":3082616,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2020-07-15T12:09:52.000Z","date":"2019-10-20","kind":"grant","acquired":true,"shares":1100000,"price":0.001,"value":1100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."}],"balance_after":2593086,"source":{"system":"sec-edgar","filing":"0001128732-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873220000005/primary_doc.xml","form_type":"4"}},{"id":3082615,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/Secretary"}}],"security":"Common Stock","published_at":"2020-07-15T12:09:52.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":550000,"price":0.001,"value":550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued by the Issuer to the Reporting Person for consulting services provided to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of Securities Acquired or Disposed of and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person."}],"balance_after":1493086,"source":{"system":"sec-edgar","filing":"0001128732-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873220000005/primary_doc.xml","form_type":"4"}},{"id":3407838,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2019-09-23T09:56:40.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":11000000,"price":0.001,"value":11000.0,"ownership":{"direct":true},"balance_after":29861719,"source":{"system":"sec-edgar","filing":"0001128732-19-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873219000025/primary_doc.xml","form_type":"4"}},{"id":3407837,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2019-09-23T09:56:40.000Z","date":"2019-09-02","kind":"grant","acquired":true,"shares":13000000,"price":0.001,"value":13000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective February 1, 2019, Issuer effectuated a reverse stock split wherein 1 share of Common Stock was issued for each 20 shares of the issued and outstanding Common Stock of the Issuer resulting in Reporting Person owning 5,861,719 shares of Common Stock of the Issuer as of that date."}],"balance_after":18861719,"source":{"system":"sec-edgar","filing":"0001128732-19-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873219000025/primary_doc.xml","form_type":"4"}},{"id":3815492,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2018-09-14T10:14:44.000Z","date":"2018-08-27","kind":"grant","acquired":true,"shares":38000000,"price":0.001,"value":38000.0,"ownership":{"direct":true},"balance_after":117234373,"source":{"system":"sec-edgar","filing":"0001128732-18-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873218000012/primary_doc.xml","form_type":"4"}},{"id":3881361,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2018-06-28T17:52:18.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":27000000,"price":0.001,"value":27000.0,"ownership":{"direct":true},"balance_after":79234373,"source":{"system":"sec-edgar","filing":"0001128732-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873218000007/primary_doc.xml","form_type":"4"}},{"id":4213597,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2017-09-08T09:45:17.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":14000000,"price":0.001,"value":14000.0,"ownership":{"direct":true},"balance_after":52234373,"source":{"system":"sec-edgar","filing":"0001128732-17-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873217000032/primary_doc.xml","form_type":"4"}},{"id":4520549,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2016-12-15T19:50:52.000Z","date":"2016-12-06","kind":"grant","acquired":true,"shares":26000000,"price":0.001,"value":26000.0,"ownership":{"direct":true},"balance_after":38234373,"source":{"system":"sec-edgar","filing":"0001128732-16-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873216000037/primary_doc.xml","form_type":"4"}},{"id":4565363,"issuer":{"id":8329,"kind":"organization","name":"Sunshine Biopharma Inc."},"owners":[{"id":121908,"kind":"person","name":"Sebaaly Camille","position":1,"cik":"0001474695","reported_name":"Sebaaly Camille","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2016-11-07T12:01:17.000Z","date":"2016-10-10","kind":"other","acquired":true,"shares":129468927,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Owned by 4019318 Canada Inc., an entity controlled by Reporting Person."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"129,468,927 shares were acquired by 4019318 Canada Inc., an entity controlled by Reporting Person, pursuant to a share exchange with an unrelated entity; no consideration was paid as a result of the share exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"129,468,927 shares were acquired by 4019318 Canada Inc., an entity controlled by Reporting Person, pursuant to a share exchange with an unrelated entity; no consideration was paid as a result of the share exchange."}],"balance_after":129468927,"source":{"system":"sec-edgar","filing":"0001128732-16-000031","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474695/000112873216000031/primary_doc.xml","form_type":"4"}}]}